Regulatory News:

The Board of Directors of Philip Morris International Inc. (NYSE: PM) today declared a regular quarterly dividend of $1.27 per common share, payable on January 11, 2023, to shareholders of record as of December 22, 2022. The ex-dividend date is December 21, 2022. For more details on stock, dividends and other information, see www.pmi.com/dividend.

Philip Morris International: Delivering a Smoke-Free Future

Philip Morris International (PMI) is a leading international tobacco company working to deliver a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company’s current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the U.S. Since 2008, PMI has invested more than USD 9 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. The U.S. Food and Drug Administration (FDA) has authorized the marketing of versions of PMI’s IQOS Platform 1 devices and consumables as Modified Risk Tobacco Products (MRTPs), finding that exposure modification orders for these products are appropriate to promote the public health. As of September 30, 2022, excluding Russia and Ukraine, PMI's smoke-free products were available for sale in 70 markets, and PMI estimates that approximately 13.5 million adults around the world had already switched to IQOS and stopped smoking. With a strong foundation and significant expertise in life sciences, in February 2021 PMI announced its ambition to expand into wellness and healthcare areas and deliver innovative products and solutions that aim to address unmet consumer and patient needs. For more information, please visit www.pmi.com and www.pmiscience.com.

Philip Morris International

Investor Relations: New York: +1 (917) 663 2233 Lausanne: +41 (0)58 242 4666 Email: InvestorRelations@pmi.com

Media: David Fraser Lausanne: +41 (0)58 242 4500 Email: David.Fraser@pmi.com

Philip Morris (NYSE:PM)
Historical Stock Chart
Von Feb 2024 bis Mär 2024 Click Here for more Philip Morris Charts.
Philip Morris (NYSE:PM)
Historical Stock Chart
Von Mär 2023 bis Mär 2024 Click Here for more Philip Morris Charts.